Fei Luo
Impact in
-
- Diet, Metabolism, and Disease
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Biochemistry top 5%
Papers in
-
- Sulfur Compounds in Biology 5
-
- Cancer, Lipids, and Metabolism 6
Fei Luo
106 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 152
- Endocrinology, Diabetes and Metabolism 283
- Biochemistry 101
- Cancer Research 174
- Cardiology and Cardiovascular Medicine 230
- Epidemiology 303
Countries citing papers authored by Fei Luo
This map shows the geographic impact of Fei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Luo more than expected).
Fields of papers citing papers by Fei Luo
This network shows the impact of papers produced by Fei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Luo. The network helps show where Fei Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 7 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 21 | |
| 10 | 2023 | 4 | |
| 11 | 2023 | 3 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 2 | |
| 14 | 2022 | 3 | |
| 15 | 2021 | 61 | |
| 16 | 2019 | 1 | |
| 17 | 2017 | 23 | |
| 18 | 2015 | 3 | |
| 19 | Design of Model Test System for Cold Regions Engineering with Dynamic Loading | 2011 | 2 |
| 20 | Central areas and post-receptor mechanisms underlying opioid physical dependence | 1999 | 1 |
About Fei Luo
Fei Luo is a scholar working on Biochemistry, Cancer Research, Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology and Cardiology and Cardiovascular Medicine, having authored 116 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Lipid metabolism and disorders (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Cancer, Lipids, and Metabolism (6 papers), Advanced Battery Materials and Technologies (5 papers), Sulfur Compounds in Biology (5 papers) and Advancements in Battery Materials (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (283 citations), Biochemistry (101 citations), Cancer Research (174 citations), Cardiology and Cardiovascular Medicine (230 citations) and Epidemiology (303 citations). Fei Luo has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiangping Li, Avash Das, Zhenfei Fang, Guiyun Ruan, Yuan Guo, Ran Peng, Panyun Wu, Jingfei Chen, Jia Peng and Federico Oldoni. Their work appears in journals such as Lipids in Health and Disease, Journal of Cellular and Molecular Medicine, World Journal of Microbiology and Biotechnology, Water and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.